Market research and consulting
Custom research and consultancy to answer your business questions
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients, physicians and consumers to deliver integrated insights.
We have a wealth of experience with medical devices, in vitro and in vivo diagnostics, imaging equipment and e-health solutions. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
We also offer real-world insights with our range of cost-effective sydicated solutions:
Immunology, Virology, Oncology, Nephrology, Cardiovascular and others
Our online syndicated tracking programme provides global marketing teams with real-time access to the key dynamics driving their market. Using appropriately designed physician panels, we provide patient chart data for a broad range of therapeutic areas and geographies.
Immunology, Atopic Dermatitis, Chronic Pain, Diabetes, NASH and others
Our patient report series offer fresh insight into the behaviour, attitudes and needs of people living with different types of chronic illness, providing a map of the patient journey from pre-diagnosis to stabilisation.
- Some example case studiesHow we conducted ethnography research to enhance new product development
The challengeThe majority of stoma patients in developing emerging markets such as India and Indonesia use external bags that are domestically manufactured or imported. We conducted research which gave internal stakeholders the necessary direction for developing a new product concept. The solutionEthnography research in the form of participant observations was conducted with 10 patients in each market who had a permanent colostomy procedure. The ethnography…read more »How we used ethnography to capture behavioural insights
The challengeHaemophilia A & B markets are highly competitive and cluttered where HCPs and patients perceive similar efficacy and safety across available products. Our client wanted to inform the design of an improved infusion device to differentiate and deliver a better experience. The challenge was to identify deeper insights from behavioural observation (beyond claimed/ stated experience) to differentiate user experience across various devices and identify…read more »How we helped our client to evaluate early biosimilar user experience
The challenge: Our client wanted to evaluate early user experience for physicians and patients across Europe of a newly launched biosimilar in an autoimmune disease. The results were needed to better understand drivers and barriers of prescribing/using biosimilars (vs. biologics) and suitable patient types to develop more targeted communication material. The solution: We opted for qualitative telephone interviews to reach a dispersed and small target…read more »
- Our latest white papersThe impact of COVID-19 on chronic disease management and the implications for pharma marketing
On February 11, 2020, COVID-19 was officially named by the World Health Organisation (WHO). Since then the novel coronavirus causing it, (a severe acute respiratory syndrome) has left its mark on almost every country in the world.read more »China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.read more »